Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
halofuginone (HT-100)
print preview
bookmark
share with colleague
General Information
Company
Halo Therapeutics LLC
Description
Oral analog of halofuginone, a collagen type I (COL1) inhibitor
Molecular Target
Collagen type I (COL1)
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Muscular dystrophy
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information